Cargando…
Long-term impact of the 70-gene signature on breast cancer outcome
Several studies have validated the prognostic value of the 70-gene prognosis signature (MammaPrint(R)), but long-term outcome prediction of these patients has not been previously reported. The follow-up of the consecutively treated cohort of 295 patients (<53 years) with invasive breast cancer (T...
Autores principales: | Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907672/ https://www.ncbi.nlm.nih.gov/pubmed/24445566 http://dx.doi.org/10.1007/s10549-013-2831-4 |
Ejemplares similares
-
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
por: Drukker, C. A., et al.
Publicado: (2014) -
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
por: Drukker, CA, et al.
Publicado: (2013) -
A breast cancer gene signature for indolent disease
por: Delahaye, Leonie J. M. J., et al.
Publicado: (2017) -
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
por: Knauer, M, et al.
Publicado: (2010) -
Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)